Disruption of Slc7a9 transporter impairs amino acid homeostasis and contributes to kidney injury in Dahl SS rats

Amino acids (AA) play a significant role in the pathophysiology of hypertension and kidney injury. Our previous studies suggest that supplementation of specific AAs, such as lysine, can mitigate hypertension and protect the kidneys, likely through inhibiting tubular albumin reabsorption. Lysine supplementation potentially enhances kidney function by removing harmful metabolites and boosting beneficial ones. Therefore, we hypothesized that disruption in lysine transport would impair AA homeostasis, subsequently affecting blood pressure and kidney function. In kidneys, b(0,+)-type amino acid transporter 1 (b(0,+)AT1) ( Slc7a9 ) is responsible for transporting dibasic AAs, including lysine. GWAS studies highlighted the role of SLC7A9 in kidney disease. We used CRISPR/Cas9 to create a Slc7a9 -/- rat model on the Dahl SS background to test the hypothesis. Disruption of the b(0,+)AT1transporter in Dahl SS rats results in various physiological and metabolic changes, including reduced body weight, hepatic steatosis, decreased diuresis, and alterations in urine sediment composition (hexagonal and needle-shaped crystals), suggesting potential kidney damage. Slc7a9 -/- rats demonstrated significant aminoaciduria, particularly increased fractional excretion of arginine (0.25 ± 0.1 & 76 ± 18 %, p <0.003), lysine (0.13 ± 0.03 & 39 ± 9 %, p <0.003), methylhistidine (1.3 ± 0.5 & 36 ± 9 %, p <0.003) and ornithine (0.1 ± 0.04 & 21 ± 5 %, p <0.002). Male SS Slc7a9-/- animals showed higher levels of albuminuria (Alb/Cre: 1.6 ± 0.2 & 2.5 ± 0.6) and altered responses to lysine supplementation (“lysine test”). Proteomic and metabolomic analyses indicate widespread changes in protein expression and metabolite levels across different organs and fluids, particularly affecting pathways related to the TCA cycle and glycolysis/gluconeogenesis. We observed higher levels of malate, citrate, cis-aconitate, glutaric, and acetoacetic acids in urine, alongside a decrease in malate levels in the heart. Single nucleus RNA-Seq and pathway analysis highlighted differential regulation of metabolic pathways, including reduced glutathione metabolism (downregulated Gpx3, Gsta1, Gsta2 in multiple cell clusters) and increased oxidative stress in Slc7a9 -/- rats. Therefore, this study highlights the critical role of Slc7a9 in maintaining AA and metabolic homeostasis, contributing to kidney injury. Supported by the Department of Veteran Affairs I01 BX004024-05 (to AS) grant. This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

Authors

Institutions

Publication Details

Journal
Physiology
Published
2025-05-01
DOI
https://doi.org/10.1152/physiol.2025.40.s1.0284
Primary Topic
Biomedical Research and Pathophysiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disruption of Slc7a9 transporter impairs amino acid homeostasis and contributes to kidney injury in Dahl SS rats

Ratnakar Tiwari, Alexander Staruschenko, Ruslan Bohovyk, Adrian Zietara et al.
Physiology
Biomedical Research and Pathophysiology
article

Disruption of Slc7a9 transporter impairs amino acid homeostasis and contributes to kidney injury in Dahl SS rats

Ratnakar Tiwari, Alexander Staruschenko, Ruslan Bohovyk, Adrian Zietara, Oleg Palygin, Yifan Tan, Markus Matthias Rinschen, Olha Kravtsova, Lashodya V. Dissanayake, Vladislav Levchenko
article en

Abstract

Amino acids (AA) play a significant role in the pathophysiology of hypertension and kidney injury. Our previous studies suggest that supplementation of specific AAs, such as lysine, can mitigate hypertension and protect the kidneys, likely through inhibiting tubular albumin reabsorption. Lysine supplementation potentially enhances kidney function by removing harmful metabolites and boosting beneficial ones. Therefore, we hypothesized that disruption in lysine transport would impair AA homeostasis, subsequently affecting blood pressure and kidney function. In kidneys, b(0,+)-type amino acid transporter 1 (b(0,+)AT1) ( Slc7a9 ) is responsible for transporting dibasic AAs, including lysine. GWAS studies highlighted the role of SLC7A9 in kidney disease. We used CRISPR/Cas9 to create a Slc7a9 -/- rat model on the Dahl SS background to test the hypothesis. Disruption of the b(0,+)AT1transporter in Dahl SS rats results in various physiological and metabolic changes, including reduced body weight, hepatic steatosis, decreased diuresis, and alterations in urine sediment composition (hexagonal and needle-shaped crystals), suggesting potential kidney damage. Slc7a9 -/- rats demonstrated significant aminoaciduria, particularly increased fractional excretion of arginine (0.25 ± 0.1 & 76 ± 18 %, p <0.003), lysine (0.13 ± 0.03 & 39 ± 9 %, p <0.003), methylhistidine (1.3 ± 0.5 & 36 ± 9 %, p <0.003) and ornithine (0.1 ± 0.04 & 21 ± 5 %, p <0.002). Male SS Slc7a9-/- animals showed higher levels of albuminuria (Alb/Cre: 1.6 ± 0.2 & 2.5 ± 0.6) and altered responses to lysine supplementation (“lysine test”). Proteomic and metabolomic analyses indicate widespread changes in protein expression and metabolite levels across different organs and fluids, particularly affecting pathways related to the TCA cycle and glycolysis/gluconeogenesis. We observed higher levels of malate, citrate, cis-aconitate, glutaric, and acetoacetic acids in urine, alongside a decrease in malate levels in the heart. Single nucleus RNA-Seq and pathway analysis highlighted differential regulation of metabolic pathways, including reduced glutathione metabolism (downregulated Gpx3, Gsta1, Gsta2 in multiple cell clusters) and increased oxidative stress in Slc7a9 -/- rats. Therefore, this study highlights the critical role of Slc7a9 in maintaining AA and metabolic homeostasis, contributing to kidney injury. Supported by the Department of Veteran Affairs I01 BX004024-05 (to AS) grant. This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.

PhysiologyVol. 40(S1)
Medical University of South Carolina (US), Aarhus University (DK), University of South Florida (US)
Openalex Percentile: Top 77%
Biomedical Research and Pathophysiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.